Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
featured
Published in Oncology

Expert Opinion / Interview · October 01, 2020

Adding Immunotherapy to First-Line Chemotherapy for Gastric Cancer: Data and Implications From CHECKMATE 649

Interview by
Daniel Catenacci MD
Interview with
Elizabeth Smyth MD

 

 Save  Recommend
 Share

Further Reading

Related Videos